Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law Firm
NEW YORK, Jan. 3, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
- Eagle Bulk Shipping Inc. (NYSE: EGLE)
Per the merger agreement, Eagle Bulk shareholders will get 2.6211 Star Bulk shares for each Eagle share, valuing each Eagle share at about $52.60. Post-merger, Star Bulk and Eagle shareholders will own roughly 71% and 29% of the merged company, respectively.
- Icosavax, Inc. (Nasdaq: ICVX)
According to the agreement terms, AstraZeneca will, via a subsidiary, start a tender offer to purchase all outstanding shares of Icosavax for $15.00 per share in cash. Additionally, shareholders will receive a non-tradable contingent value right for up to $5.00 in cash.
- Rain Oncology, Inc. (Nasdaq: RAIN)
Under the merger agreement, Pathos will buy Rain Oncology at $1.16 per share in cash, plus a non-tradeable CVR for potential extra cash payments up to $0.17 per share.
- Alteryx, Inc. (NYSE: AYX)
Under the proposed transaction, Clearlake Capital Group and Insight Partners will acquire Alteryx for $48.25 in cash for each share of Class A or Class B common stock.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
How to Get Involved:
Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-egle-icvx-rain-and-ayx-investors-to-contact-law-firm-302025655.html
SOURCE Kuehn Law, PLLC
Ausgewählte Hebelprodukte auf Alteryx A
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Alteryx A
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Rain Therapeutics Aktie News
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Rain Therapeutics Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Rain Therapeutics nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Keine Analysen gefunden.
